Form D — Cirius Therapeutics, Inc.
0000905729-25-000168 · filed 2025-10-08
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $1,200,000
- Total sold
- $800,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cirius Therapeutics, Inc.
- CIK
- 1702956
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3133 ORCHARD VISTA DR. SW
GRAND RAPIDS, MI 49546 - Phone
- 616-450-5552
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert A Beardsley · Executive OfficerGrand Rapids, MI Find on LinkedIn ↗
-
Jerry Callahan · Executive OfficerGrand Rapids, MI Find on LinkedIn ↗
-
Michael Jandernoa · DirectorGrand Rapids, MI Find on LinkedIn ↗
-
David Van Andel · DirectorGrand Rapids, MI Find on LinkedIn ↗
-
Robert Zerbe · DirectorGrand Rapids, MI Find on LinkedIn ↗
View original on SEC EDGAR.